MARKET

EVMN

EVMN

EVOMMUNE INC
NYSE
13.88
-1.18
-7.81%
Opening 12:05 06/30 EDT
OPEN
14.55
PREV CLOSE
15.05
HIGH
15.00
LOW
13.75
VOLUME
684.29K
TURNOVER
--
52 WEEK HIGH
33.20
52 WEEK LOW
13.75
MARKET CAP
499.75M
P/E (TTM)
-21.5551
1D
5D
1M
3M
1Y
5Y
1D
Evommune Is Maintained at Overweight by Morgan Stanley
Dow Jones · 4h ago
Morgan Stanley Maintains Overweight on Evommune, Lowers Price Target to $26
Benzinga · 4h ago
This AAR Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Benzinga · 4h ago
Evommune price target lowered to $26 from $55 at Morgan Stanley
TipRanks · 6h ago
Evommune Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 6h ago
HC Wainwright & Co. Downgrades Evommune to Neutral
Benzinga · 6h ago
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Palisade Bio (PALI)
TipRanks · 6h ago
Evommune price target lowered to $28 from $53 at Clear Street
TipRanks · 21h ago
More
About EVMN
Evommune, Inc. is a clinical-stage biotechnology company developing therapies that target key drivers of chronic inflammatory diseases. Its initial clinical development programs are focusing on chronic spontaneous urticaria (CSU), atopic dermatitis (AD) and ulcerative colitis (UC). Its product candidates include EVO756 and EVO301. The Company's advanced clinical-stage product candidate, EVO756, is a potent and highly selective oral small molecule antagonist of MRGPRX2, a receptor predominantly found on mast cells and peripheral sensory neurons, which is initially being evaluated in Phase II trials for the treatment of CSU and AD. The Company's second clinical-stage product candidate, EVO301, is a long-acting fusion protein consisting of an IL-18 binding protein (BP) and an anti-serum albumin Fab-associated (SAFA) domain, which is being evaluated in Phase II trials for the treatment of AD and UC.

Webull offers Evommune, Inc. stock information, including NYSE: EVMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVMN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EVMN stock methods without spending real money on the virtual paper trading platform.